Related Experiment Video
Updated: Dec 16, 2025

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Inhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammation
David P Sparling1, Nile McCullough1, Utpal Pajvani2
1Department of Pediatrics, University of Oklahoma Health Sciences Center , Oklahoma City, OK, USA.
Abstract:
Adipocyte-mediated inflammatory signalling has been proposed to alter adipose physiology in obesity and Type 2 diabetes mellitus. Novel targets for alteration of inflammatory signalling are needed to improve obesity-related outcomes. The γ-secretase enzyme complex has been suggested to play a role both in adipocyte function as well as in immune regulation. We hypothesized that adipocyte-specific γ-secretase inhibition could alter the inflammatory makeup of adipose tissue. We found that genetic blockade of γ-secretase in adipocytes leads to a decrease in EMR1 (F4/80) expression, as a marker of macrophage presence, in adipose tissue without changes in expression of markers of other inflammatory cell types. To explore the mechanism by which adipocytes can alter macrophage function in vitro, fully differentiated 3T3-L1 adipocytes were treated with a γ-secretase inhibitor in the presence of lipopolysaccharide (LPS) and transcription of IL6 and ccl2 (MCP1) were quantified. IL-6 expression and secretion were significantly inhibited by γ-secretase blockade, with little effect on MCP1. Preconditioned media from 3T3-L1 adipocytes treated with a γ-secretase inhibitor also alters macrophage activation but did not affect macrophage translocation in vitro. Therefore, γ-secretase inhibition in fully differentiated adipocytes can alter IL-6 signalling to macrophages, consistent with our hypothesis that that γ-secretase is involved in adipocyte-initiated inflammatory signalling cascades.
Insights
Inhibiting the gamma-secretase enzyme in fat cells reduces inflammatory markers like IL-6. This suggests gamma-secretase is a potential target for managing obesity and related inflammatory conditions.
Area of Science:
- Biochemistry
- Immunology
- Metabolic Diseases
Background:
- Adipocyte inflammation is implicated in obesity and Type 2 diabetes.
- Novel therapeutic targets are needed to modulate inflammatory signaling in adipose tissue.
- The gamma-secretase enzyme complex is involved in adipocyte function and immune regulation.
Purpose of the Study:
- To investigate the role of adipocyte-specific gamma-secretase inhibition in altering adipose tissue inflammation.
- To explore the mechanisms by which adipocytes influence macrophage inflammatory responses.
Main Methods:
- Genetic blockade of gamma-secretase in adipocytes.
- In vitro treatment of 3T3-L1 adipocytes with a gamma-secretase inhibitor and lipopolysaccharide (LPS).
- Quantification of inflammatory gene expression (EMR1, IL6, ccl2) and macrophage activation markers.
Main Results:
- Genetic gamma-secretase inhibition in adipocytes decreased EMR1 expression, a marker for macrophage presence.
- In vitro, gamma-secretase inhibition significantly reduced IL-6 expression and secretion in adipocytes stimulated with LPS.
- Media from inhibited adipocytes altered macrophage activation but not translocation.
Conclusions:
- Adipocyte gamma-secretase activity influences inflammatory signaling pathways.
- Gamma-secretase inhibition in adipocytes can modulate IL-6 signaling to macrophages.
- Targeting gamma-secretase in adipocytes may offer a novel strategy for managing obesity-related inflammation.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
TGF - β Signaling Pathway
Cell Specific Gene Expression
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles

